天山生物
(300313)
| 流通市值：19.54亿 | | | 总市值：23.74亿 |
| 流通股本：1.97亿 | | | 总股本：2.40亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 333,360,535.69 | 219,604,400.26 | 118,571,879.97 | 200,286,752.28 |
| 营业收入 | 333,360,535.69 | 219,604,400.26 | 118,571,879.97 | 200,286,752.28 |
| 二、营业总成本 | 331,123,793.49 | 216,996,932.89 | 114,724,076.9 | 222,453,650.55 |
| 营业成本 | 304,632,672.58 | 199,512,597.63 | 106,886,726.39 | 185,469,894.29 |
| 税金及附加 | 167,136.2 | 107,893.89 | 48,483.38 | 502,469.5 |
| 销售费用 | 2,772,813.61 | 1,834,712.41 | 874,674.84 | 2,694,028.17 |
| 管理费用 | 18,595,764.87 | 12,305,800.48 | 5,263,325.64 | 23,485,535.76 |
| 研发费用 | 494,672.98 | 272,179.94 | 140,699.75 | 1,017,968.75 |
| 财务费用 | 4,460,733.25 | 2,963,748.54 | 1,510,166.9 | 9,283,754.08 |
| 其中:利息费用 | 4,367,552.72 | 2,909,644.88 | 1,459,787.09 | 9,272,591.39 |
| 其中:利息收入 | 27,714.38 | 19,034.55 | 9,183.31 | 74,792.86 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 5,067,272.64 | 3,655,352.22 | 1,132,478.55 | 3,387,136.75 |
| 资产处置收益 | 21,998.26 | 131,698.05 | 48,245.58 | 81,149.36 |
| 资产减值损失(新) | 465,198.47 | -332,703.25 | 231,744.51 | -7,195,177.02 |
| 信用减值损失(新) | -880,250.57 | -993,122.81 | -828,450.61 | -3,765,444.2 |
| 其他收益 | 2,549,730.73 | 2,116,450.01 | 1,481,131.83 | 7,697,315.77 |
| 四、营业利润 | 9,460,691.73 | 7,185,141.59 | 5,912,952.93 | -21,961,917.61 |
| 加:营业外收入 | 62,135.18 | 62,099.28 | 83.96 | 376,737.17 |
| 减:营业外支出 | 323,890.08 | 173,465.03 | 12,556.3 | 375,095.66 |
| 五、利润总额 | 9,198,936.83 | 7,073,775.84 | 5,900,480.59 | -21,960,276.1 |
| 减:所得税费用 | 2,939,243.82 | 1,750,857.89 | 1,056,753.48 | 4,228,753.33 |
| 六、净利润 | 6,259,693.01 | 5,322,917.95 | 4,843,727.11 | -26,189,029.43 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 6,259,693.01 | 5,322,917.95 | 4,843,727.11 | -26,189,029.43 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 4,394,358.07 | 4,227,669.93 | 4,161,542.71 | -27,185,776.72 |
| 少数股东损益 | 1,865,334.94 | 1,095,248.02 | 682,184.4 | 996,747.29 |
| 扣除非经常损益后的净利润 | 1,269,585.68 | 1,110,073.29 | 2,754,449.59 | -34,472,371.98 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.02 | 0.02 | 0.02 | -0.09 |
| (二)稀释每股收益 | 0.02 | 0.02 | 0.02 | -0.09 |
| 九、综合收益总额 | 6,259,693.01 | 5,322,917.95 | 4,843,727.11 | -26,189,029.43 |
| 归属于母公司股东的综合收益总额 | 4,394,358.07 | 4,227,669.93 | 4,161,542.71 | -27,185,776.72 |
| 归属于少数股东的综合收益总额 | 1,865,334.94 | 1,095,248.02 | 682,184.4 | 996,747.29 |
| 公告日期 | 2026-10-30 | 2026-08-29 | 2026-04-25 | 2026-04-25 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |